Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 4Phase 2/3 3Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Fatigue 2Neoplasms 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Methylphenidate 2coenzyme Q10 1Vitamin E 1Surveys and Questionnaires 1Sodium Chloride 1Sildenafil Citrate 1Ritonavir 1Quality of Life 1Metformin 1Acupuncture Therapy 15,10-dihydro-5-methylphenazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Fatigue × Methylphenidate × Clear all
NCT02361125 2022-01-04

Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate

M.D. Anderson Cancer Center

Phase 1 Completed
31 enrolled

Fatigue

NCT01164956 2019-04-26

Methylphenidate for Cancer-Related Fatigue

Dana-Farber Cancer Institute

Phase 1 Terminated
3 enrolled 7 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡